About 189K results
U.S. News Room - Daiichi Sankyo US
NHS England to offer Daiichi Sankyo’s quizartinib for AML
Daiichi Sankyo and MSD’s ADC improves progression-free …
Daiichi (4568 JP) Sets Sights on Next Generation of Targeted …
Daiichi Sankyo posts positive DS-9606 clinical trial results in solid ...
Daiichi Sankyo and Merck's cancer drug meets main goal in late …
Daiichi Sankyo and Merck Announce Global Development and ...
U.S. News Room - Daiichi Sankyo US